A growing number of states are moving to cap what hospitals can charge commercial payers and employers, turning hospital pricing into one of the most active battlegrounds in state health policy.
Several states enacted hospital price caps in 2025, and the 2026 legislative sessions have brought a fresh wave of proposals tied to Medicare rates, according to The Commonwealth Fund.
Two recent developments show how far the trend has traveled, and how hard hospitals are fighting back.
Indiana moves from law to enforcement
Indiana has become the clearest test case. The state is expected to issue a report shortly, showing average hospital prices and where each facility falls on the cost spectrum, KFF Health News reported June 22.
The 2025 law caps the prices that five of the state’s largest nonprofit systems can charge patients on job-based health plans, indexing commercial prices to Medicare. It applies to systems with $2 billion or more in net patient service revenue:
- Ascension St. Vincent (Indianapolis)
- Community Health Network (Indianapolis)
- Franciscan Health (Mishawaka)
- Indiana University Health (Indianapolis)
- Parkview Health (Fort Wayne)
Together, these systems control nearly half of Indiana’s hospital market, according to KFF.
Indiana’s previous report on hospital prices, published in November, found three of the five systems surpassed voluntary benchmarks when excluding practitioner services, such as physician fees. However, all five systems were below the voluntary benchmark when physician servicers were included in the overall score.
The mechanics are aggressive. Systems must offer direct-to-employer contracts with prices capped at or below 260% of Medicare, and by June 30, 2029, they must bring prices at or below the statewide average. Systems that miss the threshold risk losing tax-exempt status for at least one year. Beginning in September, other Indiana hospitals must comply with the same provision.
Lawmakers built the case on RAND data showing Indiana employers pay prices well above the national average. In 2022, hospital prices nationally averaged 254% of Medicare, while Indiana’s averaged 297%.
However, the approach is drawing pushback.
Healthcare pricing experts argue the law could backfire, warning that narrow networks and Medicare-indexed caps do not address the underlying drivers of healthcare costs and could pressure quality. Meanwhile, hospitals are adapting: direct-to-employer contracting has gained traction in the state as systems respond to the new rules.
Michigan goes further
Michigan arguably now has the most sweeping proposal on the table. Legislation introduced June 18 by Michigan House Speaker Matt Hall would create a hospital cost review board, restrict consolidation and cap prices across the board.
Under the bill, hospitals would have to cut prices by 10% immediately or lose nonprofit status. All reimbursement would be capped at 200% of Medicare, cash-pay charges at 150% of Medicare, and annual price increases would be limited to the rate of inflation or lower, subject to board approval.
The bill also targets market power. No system could control more than 8% of statewide bed share or 3% of statewide market share, and mergers would require board approval, a rate reduction of at least 2% and a 12% tax on the purchase price.
The Michigan Health & Hospital Association has strongly opposed the measure.
MHA CEO Brian Peters said the proposal would “exacerbate the affordability challenges they seek to address,” noting Michigan ranks third lowest in the country for hospital prices relative to Medicare. He pointed to the June 19 closure of the 101-year-old Sturgis (Mich.) Hospital as evidence of the financial strain already facing the sector.
The wave is widening
Indiana and Michigan are arguably the loudest cases, but they are part of a much broader movement.
Vermont joined Indiana in 2025 as one of the first states to cap prices across the entire commercial market, tasking its Green Mountain Care Board with setting Medicare-based caps and global hospital budgets, with a commercial drug-price cap, effective January 2026, and a broader cap due by 2027, according to The Commonwealth Fund.
Other 2025 laws focused on public employee plans. Washington’s SB 5083 caps inpatient and outpatient prices for state and school employee benefit plans at 200% of Medicare, beginning Jan. 1, 2027, and New Mexico’s SB 376 authorized caps in its state employee plan.
The 2026 sessions have widened the field. In Maine, LD 2196 would cap prices charged to private payers at 200% of Medicare; Portland, Maine-based MaineHealth warned the measure would cut its revenue by about $650 million per year and put some hospitals at risk of closure, according to The Portland Press Herald.
Delaware’s SB 1 would limit prices to 250% of Medicare, unless a system operates under a state global budget, and New Jersey, Colorado and New York are weighing their own versions, according to the Healthcare Financial Management Association. Similar bills surfaced last year in Massachusetts, Montana and Oklahoma — drafted by both Democrats and Republicans — underscoring the bipartisan support behind hospital price caps, according to Health Affairs.
Additionally, some states are reaching beyond per-service caps to limit overall cost growth.
California’s Office of Health Care Affordability set a 3.5% statewide spending growth target for 2025, tightening to 3% by 2029, with stricter limits for hospitals it labels high-cost outliers, beginning at 1.8% in 2026 and falling to 1.6% by 2029. Hospital executives estimate 75% to 80% of California hospitals could breach the targets in the early years, with penalties that can rival or exceed a hospital’s margin.
Those stakes are now in court. In October, the California Hospital Association sued OHCA, calling the targets “unattainably low” and arguing the agency exceeded its authority and ignored mandates to protect access, quality and staffing.
The lawsuit notes that insurers are raising premiums 10% or more a year, even as hospital spending is capped. It also challenges OHCA’s decision to impose tighter limits on seven outlier hospitals, including Palo Alto, Calif.-based Stanford Health Care. Matt Morgan, CFO of Monterey, Calif.-based Montage Health, told Becker’s the caps could cut up to $50 million in revenue by 2028.
What the evidence says
The key question for executives is whether caps actually destabilize hospitals. Early evidence from Oregon suggests they may not, at least at a narrow scope.
A Providence, R.I.-based Brown University analysis of Oregon’s 2019 cap, which limits what the state employee health plan pays to 200% of Medicare, found the policy saved the state about $50 million a year with no statistically significant hit to hospital net patient revenue, patient care expenses or operating margins. Researchers found no service line closures, staffing cuts or clinician pay reductions tied to the cap.
The caveat matters. Oregon’s cap touched only state employees, roughly 15% of commercially insured patients.
Researchers cautioned the findings carry “important implications” for the broader wave of state reforms now underway. Indiana’s, Michigan’s and Maine’s proposals reach far more of the commercial book, which is why systems in those states project revenue losses an order of magnitude larger than Oregon’s measured effect.
Are hospital price caps going federal?
For now, the cap fight is a state story. The federal government’s lever on hospital prices has been transparency and site-neutral payments, not price ceilings.
CMS finalized price transparency rules requiring hospitals to post median and percentile allowed amounts in their machine-readable files, with enforcement beginning April 1, 2026. In June, the White House warned more than 500 hospitals to post pricing information or face fines. CMS also expanded site-neutral payment policies in its 2026 outpatient rule, aligning some hospital outpatient rates with lower-cost settings. Meanwhile, renewed scrutiny of the 340B drug discount program has systems bracing for further cuts.
What began as isolated state efforts has evolved into a broader movement to rein in hospital prices. Whether these policies ultimately lower costs without undermining hospital finances will likely shape the next chapter of healthcare affordability debates.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.